New synthesis promises to cut cost of making amine drugs
Scientists in Switzerland have developed a simple and cheap way to synthesise amines - compounds that form the backbone of many active pharmaceutical ingredients.
Archives for August 23, 2016
AMRI partners to advance RNA-based therapeutics, research tools
AMRI and the University at Albany’s RNA Institute are partnering to speed the development of new RNA-based therapeutics in an “ideal and first of its kind” collaboration.
Pharma pollution an 'ignored' cause of antibiotic resistance
Pollution in pharma supply chains is contributing to the spread of antimicrobial resistance (AMR), says a new report.
Marken expands capabilities with new pharma license at Moscow depot
Marken’s Moscow-based depot has been granted a new pharmaceutical license from the Russian Federation, further extending the company’s capabilities in the area.
New Ph I-IV data management system to provide access to clinical trial data in real time
Biomedical Systems and Foundry Health of Chicago will collaborate to develop the proprietary cloud-based data management system, which will cover all study phases.
CMO contracts will transfer to Pfizer
Pfizer to buy AstraZeneca's antibiotic business in deal worth up to $1.5bn
Pfizer will buy most of AstraZeneca’s antibiotics business in a $1.5bn (€1.32bn) deal that will see the Anglo-Swedish drug firm continue to package Merrem at its Macclesfield, UK plant for at least the next 18 months.
update - Hospira regrets non-compliance
Pfizer unit Hospira and Napp broke APBI code during Remsima push
Pfizer’s Hospira unit and Napp Pharmaceuticals broke ABPI rules covering the promotion of biosimilar medicines according to the UK industry group.